- Report
- November 2023
- 82 Pages
United States
From €3384EUR$3,500USD£2,908GBP
- Report
- February 2022
- 131 Pages
Global
From €4639EUR$4,799USD£3,988GBP
- Report
- November 2022
- 270 Pages
Global
From €5703EUR$5,899USD£4,902GBP
- Report
- March 2020
- 250 Pages
Global
From €4736EUR$4,899USD£4,071GBP
- Report
- August 2022
- 30 Pages
Global
From €3142EUR$3,250USD£2,700GBP
- Report
- August 2022
- 119 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- November 2021
- 106 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- April 2022
- 163 Pages
Global
From €7729EUR$7,995USD£6,643GBP
- Report
- June 2022
- 73 Pages
Global
From €1885EUR$1,950USD£1,620GBP
- Training
- July 2021
- 1 Day
Global
From €1062EUR$1,099USD£913GBP
- Book
- March 2021
- 320 Pages
- Book
- September 2019
- 272 Pages
- Book
- May 2018
- 560 Pages
- Book
- April 2018
- 472 Pages
- Book
- January 2018
- 536 Pages
The Marketed Drug market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of drugs that have been approved for use by regulatory authorities. This market is a crucial part of the drug discovery process, as it is responsible for bringing new treatments to the public. Companies in this market are responsible for researching, developing, and manufacturing drugs, as well as marketing and distributing them to healthcare providers and patients.
The Marketed Drug market is highly competitive, with companies competing to develop and market the most effective and safe treatments. Companies must also comply with stringent regulations and standards set by regulatory authorities.
Some companies in the Marketed Drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more